维普中文期刊产品整合服务
170篇 您的检索式:作者名="Barragan P"
    题名 作者 年代 出处 被引量
1Platelet glycoprorein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction显示文摘Montalescot G Barragan P Wittenbery O 2001N Engl J Meal2001,344,25:1
2Simple pressure parameters for mi-croirrigation design显示文摘Barragan J Wu I P 2005Biosystems Engineering2005,90,4:1
3Platelet glycoprotein Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction显示文摘Montalescot G Barragan P Wittenbery O 2001N Eng J Med2001,21,:1
4Validation of a novel ELISA-based VASP whole blood assay to measure P2YI2- ADP receptor activity 显示文摘BARRAGAN P PAGANELLI F CAMOIN-Jau L 2010Thromb Haemost2010,104,2:1
5Platelet glycoprotein Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction显示文摘Montalescot G Barragan P Wittenberg O 2001N Engl J Med2001,344,25:1
6Unpr- otected left main coro-nary artery stenting:immediate and medium-term outcomes of 140 elective procedures显示文摘SILVESTRI M BARRAGAN P SAINSOUS J 2000J Am Coil Cardiol2000,35,6:1
7Platelet glycoprotein Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction显示文摘Montalescot G Barragan P Wittenberg O 0,,25:1
8Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation显示文摘Barragan P Bouvier J L Roquebert P O 2003Cather Cardiovasc Interv2003,59,3:1
9Assessment of emission uniformity for micro-irrigation design显示文摘Barragan J Bralts V Wu I P 2006Biosystems Engineering2006,93,1:1
10Platetet glycoperotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction显示文摘Montalescot G Barragan P Witeenberg O 0,,25:1
11Pla- telet glycoprotein Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial Infarction显示文摘MONTLECOT G BARRAGAN P WITTENBERG O 2001N Eng J Med2001,344,25:1
12Lack of association of CYP3A4-V polymorphism with the risk of treatment-related leukemia显示文摘Collado M Barragan E Bolufer P 2005Leuk Res2005,29,5:1
13Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation显示文摘Barragan P Bouvier J L Roquebert P O 2003Cat heter Cardiovasc Interv2003,59,3:1
14Resistance to thienopyridines:clinical detection of coronary stent thrombosis by monitoring of vasodilator stimulated phosphoprotein phos- phorylation显示文摘Barragan P Bouvier JL Roquebert PO 2003Catheter Cardiovasc Interv2003,59,3:1
15Abciximab associated with primary angioplasty and stenting in acute myocardial infarction:The ADMIRAL study,30-day final results显示文摘 Barragan P Wittenberg O 1999Circulation1999,100,:1
16Assessment of the trackability, flexibility, and conformability of coronary stents: a comparative analysis显示文摘Rieu R Barragan P Garitey V 2003Catheter- ization and Cardiovascular Interventions2003,59,4:1
17Biodegration of organochlorine pesticides by bacteria grown in microniches of the porous structure of green bean coffee显示文摘Barragan H B Costa P C Peraha C J 2007International Biodeterioration & Biodegradation2007,59,3:1
18Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement显示文摘Martin G Barragan E Bolufer P 2000Haematologica2000,85,7:1
19Long-term clinical outcomes with sirolimus-eluting coronary stentsz flve-year re- sults of the RAVEL trial显示文摘Morice MC Serruys PW Barragan P 2007J Am Coil Cardiol2007,50,14:1
20Mekl/2 MAPK ki- nases are essential for mammalian development, homeostasis and Raf -induced hyperplasia 显示文摘Scholl F A Dumesic P A Barragan D I 2007Developmental Cell2007,12,:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费